67346-50-3 Usage
Uses
Used in Pharmaceutical Industry:
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [S-(R,S)]is used as an active pharmaceutical ingredient for the development of drugs targeting specific receptors or pathways in the body. Its unique molecular structure allows it to interact with biological targets, making it a promising candidate for the treatment of various diseases.
Used in Chemical Synthesis:
In the field of chemical synthesis, Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [S-(R,S)]can be used as a building block or intermediate in the synthesis of more complex organic compounds. Its unique functional groups and chiral center make it a valuable component in the development of new molecules with specific properties and applications.
Used in Research and Development:
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [S-(R,S)]can be utilized in research and development for the study of its properties, interactions with biological systems, and potential applications. Its unique structure and chirality make it an interesting subject for scientific investigation, which could lead to new discoveries and advancements in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 67346-50-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,3,4 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 67346-50:
(7*6)+(6*7)+(5*3)+(4*4)+(3*6)+(2*5)+(1*0)=143
143 % 10 = 3
So 67346-50-3 is a valid CAS Registry Number.
67346-50-3Relevant academic research and scientific papers
Enantio- and diastereoselective synthesis of all four stereoisomers of formoterol
Hett, Robert,Fang, Qun Kevin,Gao, Yun,Hong, Yaping,Butler, Hal T.,Nie, Xiaoyi,Wald, Stephen A.
, p. 1125 - 1128 (2007/10/03)
Enantioselective syntheses of all four stereoisomers of formoterol are accomplished using asymmetric catalytic borane reductions with chiral oxazaborolidines as reducing agents.
